SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-401023
Filing Date
2013-10-16
Accepted
2013-10-16 16:06:53
Documents
4
Period of Report
2013-10-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d612504d8k.htm 8-K 16652
2 EX-10.1 d612504dex101.htm EX-10.1 263466
3 GRAPHIC g612504image-001.jpg GRAPHIC 87380
4 GRAPHIC g612504image-002.jpg GRAPHIC 68421
  Complete submission text file 0001193125-13-401023.txt   496238
Mailing Address 601 GATEWAY BLVD. SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BLVD. SUITE 200 SOUTH SAN FRANCISCO CA 94080 650-745-7802
HYPERION THERAPEUTICS INC (Filer) CIK: 0001386858 (see all company filings)

IRS No.: 611512713 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35614 | Film No.: 131154313
SIC: 2834 Pharmaceutical Preparations